Saul Villeda

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA.

Grifols, Inc. manufactures pharmaceuticals. The company is headquartered in Los Angeles, CA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA.

The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA.

BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL.

Biomat USA, Inc. provides plasma derived blood products. The company is headquartered in Los Angeles, CA.

Part of Roche Holding AG, Roche Diagnostics KK is a Japanese company that manufactures and sells medical equipment. The company is based in Tokyo, Japan. The company was founded in 1932. The CEO is Shin Ogasawara.

REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.

Knapp, Petersen & Clarke PC is a law firm that offers a variety of legal services. The private company is based in Glendale, CA. The firm emphasizes its creativity and accessibility in providing these services.

Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million.

GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA.

Consorzio per il Centro di Biomedicina Molecolare SCRL develops local health programs. It manages projects and organizes activities in the biomedicine, biotechnology, and bioinformatics sectors. The company is headquartered in Trieste, Italy.

The Institute of Molecular & Cell Biology engages in biomedical research. The non-profit company is based in Singapore, Singapore.

Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA.

Pulse Infoframe, Inc. operates as a cloud-based health care analytics company. Its products include dynamic registries, patient reported outcomes, visualizations and analytics, patient engagement portal. The firm's services include collaborative clinical research, workflow optimization, consulting, cloud enabled global sourcing, interoperability and deployment services. The company was founded by Femida Gwadry-Sridhar in 2011 and is headquartered in London, Canada.

Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom.

Xperiome Ltd. operates online community platform. Its services include online health communities, patient education, career education, and patient recruitment. The company was founded by Julie Walters and Peter Coe in 2007 and is headquartered in London, the United Kingdom.

Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California.

Grifols Innovation & New Technologies Ltd. provides research and experimental development services in biotechnology sector. The company was founded on December 21, 2015 and is headquartered in Dublin, Ireland.

Genialis, Inc. develops software for biologists in solving complex analyses. The software helps in automation of data and analyzing task for exploring and sharing the results. The company is headquartered in Houston, TX.

Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong.

EspeRare Foundation offers treatments for rare diseases. The non-profit company is based in Geneva, Switzerland.

Reach52 Asia Pte Ltd. engages in the provision of accessible and affordable healthcare services to communities where healthcare access is limited. It offers services to communities, healthcare providers, governments, multi-laterals, and institutions. The company was founded by Ed Booty in 2017 and is headquartered in Singapore.